Insider Transactions Reported by 22 Insiders of Nuvalent, Inc.

Symbol
NUVL on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Nuvalent, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James E. Flynn Director, Director by Deputization, 10%+ Owner $1.64B -$70.9M -4.14% 24 Nov 2025
Matthew Shair Director $174M -$7.16M -3.94% 24 Nov 2025
Andrew Hack Director $128M 11 Dec 2024
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner $68.3M 02 Aug 2021
DEERFIELD PARTNERS, L.P. Director, Director by Deputization, 10%+ Owner $49.5M 03 Nov 2022
Deborah Ann Miller Chief Legal Officer $5.25M -$8.05M -60.5% 17 Nov 2025
Darlene Noci Chief Development Officer $5.22M -$5.75M -52.4% 28 Nov 2025
Christopher Durant Turner Chief Medical Officer $5.04M -$320K -5.97% 06 Jan 2025
Grant C. Bogle Director $437K 18 Jun 2025
Sapna Srivastava Director $385K 18 Jun 2025
Michael L. Meyers Director $385K 18 Jun 2025
Anna Protopapas Director $385K 18 Jun 2025
Cameron Wheeler Director $385K 18 Jun 2025
Joseph Pearlberg Director $385K 18 Jun 2025
Christy J. Oliger Director $297K 18 Jun 2025
Ron Squarer Director $240K 10 Dec 2025
Emily Conley Director $213K 23 Aug 2024
Dwight Gary Gilliland Director $206K 12 Jun 2024
James Richard Porter President and CEO, Director $199K -$22.3M -99.1% 19 Dec 2025
Alexandra Balcom Chief Financial Officer $96.3K -$14.2M -99.3% 22 Dec 2025
Henry E. Pelish Chief Scientific Officer $76.7K -$4.57M -98.3% 22 Dec 2025
Robert Bowers Jackson Director 28 Jul 2021

Recent Insider Transactions by Companies or Individuals for Nuvalent, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.